Strontium-89

Radiochemicals

Description
Radioactive strontium therapy with Sr-89 treats cancers that have spread to the bone. The radioactive strontium targets the cancer cells in the bone. Strontium Chloride Sr-89 is indicated for the relief of bone pain in patients with painful skeletal metastases.

Status
Inquire

Radionuclidic purity
> 99.0%

Radiochemical purity
>—%

Chemical formula
SrCl2

Concentration
> 10 mCi/ml

Specific activity
—

Half life
50.57 days

Calibration
—

Form
0.1-0.5 M HCl solution

Regions
Africa, Asia, Australia, Canada, Europe, Latin America, Middle East, USA

Decay Calculator

Initial activity

mCi

Elapsed time

days


Final activity